FDA Approves World's First Automated Insulin Pump For Diabetics
The US Food and Drug Administration has approved Medtronic's MiniMed 670G, a medical device that monitors a diabetic's sugar levels, and then automatically injects the required dose of
This first-of-its kind automated insulin delivery system was approved for people over the age of 14 who have
People with type 1
"[MiniMed 670G] can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," the FDA's Jeffrey Shuren said in a release.
MiniMed 670G includes a sensor that attaches to the body to measure glucose levels under the skin, an insulin pump that's strapped to the body, and a catheter that delivers the insulin. The insulin delivery site needs to be changed about twice a week.
The device has been referred to as an "
The FDA approved Medtronic's MiniMed 670G following a successful clinical trial that included 123 participants with type 1 diabetes. During the course of the three-month trial, no serious or adverse effects-such as diabetic ketoacidosis (DKA) or severe hypoglycemia (low glucose levels-were reported.
Medtronic, a medical tech firm based in Dublin, Ireland, says the device will be made available to the public in the spring of 2017. Looking ahead, the company plans to refine and further test the device in the hope that children under of the age of 14 can also use it.